Latest News on Glenmark Pharma q4
Showing of 0 - 10 from 1 results
Glenmark Pharma q4 - Total results - 1
May 30, 2019
Glenmark Q4 net profit up 6.62% at Rs 162 cr; board approves raising funds up to $200 mn through debt securitiesGlenmark Pharma's consolidated revenue for 2018-19 stood at Rs 9,865.46 crore, compared to Rs 9,103.07 crore in the preceding fiscal.